PFBT
RGNX icon

Parkside Financial Bank & Trust’s Regenxbio RGNX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70
Closed -$501 – 2958
2025
Q1 		$501 Buy
+70
New +$521 ﹤0.01% 2388
2024
Q4 		– Sell
-18
Closed -$189 – 2181
2024
Q3 		$189 Hold
18
– – ﹤0.01% 2018
2024
Q2 		$211 Buy
18
+13
+260% +$202 ﹤0.01% 1942
2024
Q1 		$106 Buy
+5
New +$89 ﹤0.01% 2011
2023
Q4 		– Sell
-13
Closed -$214 – 2156
2023
Q3 		$214 Sell
13
-50
-79% -$906 ﹤0.01% 1985
2023
Q2 		$1.26K Buy
63
+58
+1,160% +$1.12K ﹤0.01% 1794
2023
Q1 		$95 Sell
5
-156
-97% -$3.45K ﹤0.01% 1994
2022
Q4 		$3.65K Buy
161
+101
+168% +$2.28K ﹤0.01% 1457
2022
Q3 		$2K Buy
60
+9
+18% +$267 ﹤0.01% 1578
2022
Q2 		$1K Sell
51
-36
-41% -$899 ﹤0.01% 1752
2022
Q1 		$3K Sell
87
-85
-49% -$2.36K ﹤0.01% 1521
2021
Q4 		$6K Buy
172
+42
+32% +$1.43K ﹤0.01% 1251
2021
Q3 		$5K Sell
130
-64
-33% -$2.3K ﹤0.01% 1267
2021
Q2 		$8K Buy
194
+85
+78% +$3.04K ﹤0.01% 1063
2021
Q1 		$4K Hold
109
– – ﹤0.01% 1297
2020
Q4 		$5K Buy
+109
New +$3.81K ﹤0.01% 1129
2020
Q3 		– Sell
-23
Closed -$1K – 1631
2020
Q2 		$1K Buy
23
+12
+109% +$447 ﹤0.01% 1371
2020
Q1 		$0 Sell
11
-21
-66% -$875 ﹤0.01% 1615
2019
Q4 		$1K Hold
32
– – ﹤0.01% 1456
2019
Q3 		$1K Sell
32
-13
-29% -$527 ﹤0.01% 1426
2019
Q2 		$2K Hold
45
– – ﹤0.01% 1214
2019
Q1 		$3K Buy
+45
New +$2.23K ﹤0.01% 1092
2018
Q4 		– Sell
-20
Closed -$2K – 1551
2018
Q3 		$2K Buy
20
+1
+5% +$72 ﹤0.01% 1117
2018
Q2 		$1K Buy
+19
New +$907 ﹤0.01% 1335

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Parkside Financial Bank & Trust's RGNX Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 70 shares — an estimated $501 sold.

Parkside Financial Bank & Trust first reported a position in RGNX in Q2 2018 and held it in 24 quarters. The position peaked at $8K in Q2 2021. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 70 Regenxbio shares in Q2 2025, an estimated $501.
  • Parkside Financial Bank & Trust first reported a position in Regenxbio in Q2 2018 and held it in 24 quarters.
  • Parkside Financial Bank & Trust's Regenxbio position peaked at $8K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.